PR13.5 PROMOTER FOR ROBUST T-CELL AND ANTIBODY RESPONSES

    公开(公告)号:EP3778904A1

    公开(公告)日:2021-02-17

    申请号:EP20172647.8

    申请日:2013-10-28

    摘要: The invention encompasses recombinant poxviruses, preferably modified Vaccinia Ankara (MVA) viruses, comprising a Pr13.5 promoter operably linked to a nucleotide sequence encoding an antigen and uses thereof. The invention is drawn to compositions and methods for the induction of strong CD8 T cell and antibody responses to a specific antigen(s) by administering one or more immunizations of the recombinant MVA to a mammal, preferably a human.

    METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES

    公开(公告)号:EP3639851A1

    公开(公告)日:2020-04-22

    申请号:EP19164313.9

    申请日:2013-03-15

    IPC分类号: A61K39/12 A61K39/00

    摘要: Provided herein are immunogenic compositions comprising a recombinant modified vaccinia virus Ankara (MVA) comprising a nucleic acid sequence encoding a CD40 ligand (CD40L) and a nucleic acid sequence encoding a heterologous disease-associated antigen, wherein the immunogenic composition induces increases T-cell immune responses specific for the heterologous disease-associated antigen when administered to a human host, and related methods and uses.